Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.

ABSTRACT:

Objective

To investigate depression frequency, severity, current treatment, and interactions with somatic symptoms among patients with neuromyelitis optica spectrum disorder (NMOSD).

Methods

In this dual-center observational study, we included 71 patients diagnosed with NMOSD according to the International Panel for NMO Diagnosis 2015 criteria. The Beck Depression Inventory (BDI) was classified into severe, moderate, or minimal/no depressive state category. We used the Fatigue Severity Scale to evaluate fatigue. Scores from the Brief Pain Inventory and the PainDETECT Questionnaire were normalized to estimate neuropathic pain. Psychotropic, pain, and immunosuppressant medications were tabulated by established classes.

Results

Twenty-eight percent of patients with NMOSD

SUBMITTER: Chavarro VS 

PROVIDER: S-EPMC5079380 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature